AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 163 filers reported holding AGIOS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 1.81 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,886 | -40.6% | 157 | -32.0% | 0.00% | -100.0% |
| Q2 2023 | $6,542 | +199.8% | 231 | +143.2% | 0.00% | – |
| Q1 2023 | $2,182 | -47.8% | 95 | -36.2% | 0.00% | -100.0% |
| Q4 2022 | $4,184 | +39.5% | 149 | +33.0% | 0.00% | 0.0% |
| Q3 2022 | $3,000 | +50.0% | 112 | +51.4% | 0.00% | – |
| Q2 2022 | $2,000 | – | 74 | +572.7% | 0.00% | – |
| Q1 2022 | $0 | -100.0% | 11 | -88.5% | 0.00% | – |
| Q4 2021 | $3,000 | -50.0% | 96 | -28.9% | 0.00% | -100.0% |
| Q3 2021 | $6,000 | -14.3% | 135 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,000 | 0.0% | 135 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $7,000 | +16.7% | 135 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $6,000 | -14.3% | 135 | -27.8% | 0.00% | -50.0% |
| Q3 2020 | $7,000 | -30.0% | 187 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $10,000 | +100.0% | 187 | +38.5% | 0.00% | +50.0% |
| Q1 2020 | $5,000 | -16.7% | 135 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $6,000 | – | 135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rock Springs Capital Management LP | 3,057,869 | $86,477,000 | 2.23% |
| Eagle Health Investments LP | 329,713 | $9,324,000 | 2.14% |
| Bellevue Group AG | 4,058,792 | $114,783,000 | 1.65% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 959,214 | $27,127,000 | 1.13% |
| ARMISTICE CAPITAL, LLC | 1,924,000 | $54,411,000 | 0.94% |
| Integral Health Asset Management, LLC | 100,000 | $2,828,000 | 0.55% |
| Monarch Partners Asset Management LLC | 57,820 | $1,635,000 | 0.49% |
| ArrowMark Colorado Holdings LLC | 1,380,389 | $39,037,000 | 0.48% |
| AlphaCentric Advisors LLC | 15,000 | $424,000 | 0.44% |
| PDT Partners, LLC | 72,778 | $2,058,000 | 0.31% |